| Sharon Bio Medicine has reported a consolidated total income from operations of Rs 104.69 crore and a net loss of Rs 70.74 crore for the quarter ended Dec '15. | | For the quarter ended Dec 2014 the consolidated total income from operations was Rs 238.48 crore and net loss was Rs 107.63 crore. | | Sharon Bio Medi shares closed at 18.75 on February 15, 2016 (NSE) and has given 5.34% returns over the last 6 months and -13.79% over the last 12 months. |
|
| | Sharon Bio Medicine | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '15 | Sep '15 | | | Jun '14 | | Net Sales/Income from operations | 104.69 | 112.99 | | | 349.52 | | Other Operating Income | -- | -- | | | -- | | Total Income From Operations | 104.69 | 112.99 | | | 349.52 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 84.43 | 95.51 | | | 265.77 | | Purchase of Traded Goods | -- | 3.56 | | | 57.13 | | Increase/Decrease in Stocks | 4.18 | -5.53 | | | -30.36 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | -- | -- | | | 6.57 | | Depreciation | 5.01 | 5.00 | | | 2.99 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | 6.92 | 6.93 | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 7.03 | 8.21 | | | 5.96 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -2.88 | -0.67 | | | 41.47 | | Other Income | 0.67 | 0.72 | | | 1.15 | | P/L Before Int., Excpt. Items & Tax | -2.21 | 0.05 | | | 42.62 | | Interest | 17.94 | 16.72 | | | 14.18 | | P/L Before Exceptional Items & Tax | -20.15 | -16.67 | | | 28.44 | | Exceptional Items | -50.59 | -59.11 | | | -1.45 | | P/L Before Tax | -70.74 | -75.79 | | | 26.99 | | Tax | -- | -- | | | 6.45 | | P/L After Tax from Ordinary Activities | -70.74 | -75.79 | | | 20.54 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -70.74 | -75.79 | | | 20.54 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -70.74 | -75.79 | | | 20.54 | | Equity Share Capital | 23.79 | 23.79 | | | 21.11 | | Reserves Excluding Revaluation Reserves | -- | -- | | | 341.64 | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -6.70 | -7.18 | | | 1.95 | | Diluted EPS | -6.70 | -7.18 | | | 1.37 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -4.95 | -5.30 | | | 1.95 | | Diluted EPS | -4.95 | -5.30 | | | 1.37 | | Public Share Holding | | | | | | | No Of Shares (Crores) | -- | -- | | | 4.20 | | Share Holding (%) | -- | -- | | | 39.80 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | -- | | | 0.50 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | | | 7.94 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | | | 4.73 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | -- | -- | | | 6.36 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | | | 92.60 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | | | 55.47 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
